Denali Therapeutics (DNLI)
(Delayed Data from NSDQ)
$30.91 USD
-0.14 (-0.45%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $30.90 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.61 | 0.00% |
Earnings Summary
For their last quarter, Denali Therapeutics (DNLI) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.68 per share. This reflects a positive earnings surprise of 13.24%. Look out for DNLI's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year increase of 15.28%.
Earnings History
Price & Consensus
Zacks News for DNLI
Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
DNLI: What are Zacks experts saying now?
Zacks Private Portfolio Services